Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Agreement to Provide DehydraTECH(TM) Technology to Cannadips CBD

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, this morning announced that it has reached a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD, the Original Smokeless CBD Dip Brand. According to the update, each tin of Cannadips contains 15 pouches, each with 10mg of hemp-derived CBD, and includes only natural sweeteners with no tobacco or nicotine. Already established as the leader in CBD oral delivery, Lexaria has been working behind the scenes with the Boldt Runners team to elevate the product experience. “In our quest to create the ultimate smokeless, oral cannabinoid experience for our customers, we found that the DehydraTECH technology solves many challenges and propels the product forward as we pioneer this product category,” The Boldt Runners Corporation Founder and Chief Executive Officer Case Mandel said in the news release. “Through our strong distribution partnership with Kretek International, and our family of strategic retail partners including Sheetz, Kwiktrip, and Circle K we are stoked for the DehydraTECH technology to shine through our tins.”

To view the full press release, visit http://cnw.fm/JFU8k

About Lexaria Bioscience Corp.

Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – Congressional Committee to Debate Two Marijuana Legalization Bills This Week

On Friday, a memo briefing to the effect that when the legislative session starts this week, a Congressional committee would be debating two legislations seeking to legalize marijuana at the federal level as well as other marijuana research legislations.

On Wednesday, the House Energy and Commerce subcommittee will hold a hearing on several reform proposals, with testimonies from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), and National Institute on Drug Abuse (NIDA) witnesses.

This comes two months after the House Judiciary Committee approved the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, which was sponsored by Chairman Jerrold Nadler (D-NY). The MORE Act is one of the bills being taken up by the Energy and Commerce Subcommittee on Health on January 15.

The obtained memo starts by detailing the content of the marijuana policy in the U.S., such as the restrictions imposed by the Controlled Substances Act (CSA) on marijuana research, legalization of industrial hemp, petitions submitted in the past seeking for marijuana rescheduling, and public health issues.

Some of the witnesses for the scheduled hearing include Matthew Strait, who is the DEA Senior Policy Advisor, FDA Deputy Director for Regulatory Programs Douglas Throckmorton, and the Director of NIDA Nora Volkov.

Discussed below are some of the bills which will be debated next week.

Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act

The MORE Act aims to remove marijuana from the list of controlled substances Act. It is also seeking for expungement of the records of past marijuana convictions, as well as imposing a five percent tax on marijuana sales. Revenues from the sales would be reinvested in communities most affected by the war against drugs.

The MORE Act would also create a way for resentencing people jailed for marijuana felonies. It would also ensure that immigrants are not denied citizenship because of marijuana. The bill has provisions to ensure that weed users are not blocked from receiving public benefits and security clearance by federal agencies.

Marijuana Freedom and Opportunity Act

The legislation was sponsored by Rep. Hakeem Jeffries (D-NY). The bill’s provisions are to deschedule marijuana at the federal level, create a fund that supports minorities and marijuana businesses owned by women as well as providing grants to marijuana ex-convicts.

Medical Marijuana Research Act of 2019

It was sponsored by Rep. Matt Gaetz (R-FL). The bill seeks approval of more manufacturers of research-grade cannabis, protects institutions researching weed, and gives permission to the Department of Veteran Affairs in the U.S. to present patients with the option of treating their conditions using marijuana.

Medical Marijuana Research Act of 2019

A bipartisan group of House members led by Rep. Earl Blumenauer (D-OR) introduced the legislation. It has provisions simplifying the process of registration for researchers interested in studying marijuana. It also permits private manufacturers to supply researchers with research-grade marijuana.

Legitimate Use of Medicinal Marijuana Act

It was introduced by Rep. Morgan Griffith (R-VA). It aims at moving marijuana from Schedule I to Schedule II. It also aims at clarifying that transportation, use, possession, production, and distribution of medical marijuana cannot be prohibited by the federal government.

Veterans Medical Marijuana Safe Harbor Act

It was sponsored by Rep. Barbara Lee (D-CA). Its aim is to allow military veterans to use, possess, or transport medical pot under federal law. Veteran Affairs doctors would also be permitted to recommend medical marijuana to their patients.

It would be eye-opening to hear what industry actors like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) think of the odds that those bills will make it through both legislative chambers and become law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – 5 Common Myths About Legal Marijuana in Illinois

Although nearly two weeks have passed since the sale of recreational marijuana was launched in Illinois, some people are still confused about the workings of the state law. Discussed below are five myths about legal pot in Illinois.

Legal means no limit

Adult-use marijuana in Illinois is permissible, but only people aged 21 or above are allowed to use and possess marijuana. People can possess a maximum of 30 grams of marijuana bud and can only buy it from a licensed dispensary within the state.

Registered medical marijuana patients in Illinois can grow a maximum of five plants at their home, and it should be hidden from the public.

You can smoke weed anywhere

Some of the marijuana consumption restrictions include not using while driving, or on school grounds. Public consumption of marijuana is also prohibited, and this includes parks, sidewalks, and even in restaurants or bars where cigar and cigarette smoking is illegal. However, Illinois will issue permits to the establishments that want to set up smoking lounges. Besides, dispensaries interested in setting up smoking zones in their shops would also be permitted.

The local police is responsible for arresting marijuana offenders. Although they said that their focus would not be on the low-level offender, Naperville police warned marijuana users in a Facebook video that anyone found violating the new law would be liable to civil litigation.

People should also note that Illinois law does not operate beyond the borders of the state, thus if you are caught with weed at an airport, be sure that the federal authorities could take action against you.

Illinois is tracking weed users

When customers are buying weed from dispensaries, they are asked to present their identification, such as driver’s license, which is scanned to verify its legitimacy. It provides proof of their age and residency because under Illinois law, out of state buyers cannot buy or possess much weed. However, state law prohibits the dispensaries from holding onto the customer’s data. But information (name) on medical marijuana patients is kept in a state database.

Marijuana users cannot have guns

Marijuana consumption for gun owners is a topic that has gained traction on social media. The Illinois State Police issued a statement saying that marijuana usage is not a good enough reason to revoke Firearm’s Owners Identification or Concealed Carry Licenses. However, it would withdraw or deny the permit if the person is addicted or is a habitual consumer of narcotics, as well as those who violate the Cannabis Regulation and Tax Act.

Since the state has the name of all medical marijuana patients, it will be more difficult for medical marijuana patients to buy a gun in Illinois than it is for adult-use marijuana users because of its anonymity.

Tax rates are capped

In Illinois, adult-use marijuana is subject to a state tax and a special marijuana tax, which depends on the level of THC. The tax rate ranges from 10% to 25%. The higher the level of THC, the higher the tax rate.

The price of weed could still go up because as of July 2020, local cities can impose a maximum tax rate of up to 3% on all marijuana sales.

The best way to avoid believing myths is by proactively seeking accurate information. Experts therefore recommend that you always read the information shared by cannabis companies like HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) and No Borders Inc. (OTC: NBDR) or contact the state cannabis regulators if in doubt.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Anticipates Significant Opportunities in China for CBD, Hemp-Infused Cosmetic Products

ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang provided an update regarding the company and its CBD Biotech subsidiary in a recent SmallCapVoice.com interview (http://cnw.fm/v1kML). An article discussing the company reads, “In the interview, Wang explains the enormous market opportunity in China for CBD/hemp-infused cosmetic products, such as lotion and anti-aging cream. . . . While the sale of hemp and CBD oil in cosmetics is permitted, China has not yet approved these products for use in food or medicine; however, given worldwide legalization trends, this is likely to change in the near future. CBD Biotech is an early player in China’s CBD sector, and Wang is optimistic about the company’s future in the promising market. ‘CBD-infused or hemp-infused cosmetic products [are] still very early stage in China,’ he said. ‘We are only one of few players in the market, and I think 2020 will give us a lot of opportunities.’”

To view the full article, visit http://cnw.fm/KDS7u

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Platform Boosts CBD Absorption Levels

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative DehydraTECH(TM) delivery platform is patented for all nonpsychoactive cannabinoids as well as for tetrahydrocannabinol (THC) and psychoactive cannabinoids. An article discussing the company reads, “Medical researchers have struggled to find ways to penetrate the blood brain barrier effectively to transport beneficial drugs for many years. This barrier exists to block toxic or otherwise dangerous substances from entering the brain and is formed by layers of microvascular endothelial cells inside blood vessels. Lexaria’s DehydraTECH(TM) drug delivery platform brings beneficial drugs to the brain faster. . . . In June 2019, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. This series built on the company’s original, independent, third-party laboratory in vitro lab experiments began in 2015, which showed utilization of the DehydraTECH drug-delivery platform increased the absorption levels of cannabidiol (CBD) in human intestinal cells by an impressive 499%. The results of the studies showed delivery of 1,937% more CBD into animal brain tissue after eight hours using the enhanced DehydraTECH technology in comparison with generic industry MCT coconut-oil formulations. Moreover, the animal studies using the enhanced formulation showed an 811% increase of CBD delivery into the blood in comparison with generic MCT coconut-oil formulations.”

To view the full article, visit http://cnw.fm/84SZu

About Lexaria Bioscience Corp.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – NECANN Boston 2020 Inaugural Competition to Recognize Best Industry Offerings

NECANN Boston 2020, widely regarded as the most important cannabis industry event on the east coast, will host the first-ever NECANN competition. The inaugural competition is a third-party review of cannabis, cannabis products and ancillary cannabis products and is designed to recognize the best offerings in the industry. Companies, brands, dispensaries, home growers, caregivers and patients are all invited to enter the competition. NECANN events offer invaluable insight and essential information about every facet of the cannabis industry, including many topics such as legalization, banking, payment processing, packaging, cultivation, manufacturing, hemp, hydroponics, legal resources, and much more.

To view the full press release, visit http://cnw.fm/00OLd

About NECANN

The New England Cannabis Network (“NECANN”) has been creating resource hubs for the rapidly expanding cannabis industry since 2014. NECANN’s events are where businesses, entrepreneurs, investors, educators, patients, advocates and consumers can connect, learn and grow. Individually created conventions focused on each local market’s unique needs and opportunities are a superior alternative to the generic national canna-convention franchises found everywhere. NECANN takes a collaborative approach to each convention that has resulted in consistently high ROI for exhibitors, sponsors and attendees and the local cannabis market. Cannabis-related advocacy groups or non-profits are encouraged to contact NECANN, which is proud to sponsor donated booths wherever NECANN local cannabis conferences are held. For more information about NECANN’s flagship conference taking place March 20-22, 2020, visit: https://NECANN.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Neutra Corp. (NTRR) Announces Successful Year Full of Achievements

Neutra Corp. (OTC: NTRR) on Friday announced a long list of its achievements for the past 12 months and looks forward to more positive results in 2020. Among Neutra’s reported accomplishments were the company’s addition of Dr. Scott E. Cherry, DO, MPH, FACOEM to assist in tapping into the sports performance market, as well as its VIVIS Acquisition. “We had a great 2019, and while it’s satisfying to look back, it’s also time for Neutra to focus on the opportunity ahead,” Neutra’s CEO Sydney Jim said in the news release. “Our goal is to become a vertically integrated company in control of its hemp supply, manufacturing and production, and sales and marketing to consumers. We made solid progress in 2019 and expect to continue the move forward in 2020.”

To view the full press release, visit http://cnw.fm/4pDcM

About Neutra Corp.

Neutra Corp. (OTC: NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which it intends to participate. For more information, visit the company’s website at www.NeutraInc.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Study Finds People Have More Sex When Medical Marijuana is Legalized

A recent study by the University of Connecticut and Georgia State University found that medical marijuana legalization seems to be encouraging people to engage more in sexual activities. The researchers also found that since medical marijuana policies were enacted, there has been a decrease in the consumption of contraceptives, and an increase in the number of children born.

To figure out how marijuana laws influence sexual activity in people, the researchers analyzed data collected between 1997 and 2011. The analyzed data included responses to questions about sexual activities and drug consumption. The poll asked the participants about their cannabis consumption and sex frequency.

After analyzing the data, the researchers found that there was a 4.3% increase in the likelihood of the respondents participating in sexual activities in the past one month once a medical marijuana law was enacted and an increase in sex immediately after the law change.

The change in marijuana laws caused a two percent increase in the number of births, which means that each quarter there are more than 684 births for all women who can bear children.

The authors wrote that the results of the analysis provide evidence of the fact that marijuana consumption has a significant, unplanned, and positive impact on the number of children born. The paper was published in the Journal of Health Economics in December 2019.

The researchers also touch on the sensory impact of marijuana. Weed consumption alters people’s attitudes towards risky behaviors, making them less concerned about the outcome of sexual activities, and this possibly results in the reduced use of contraceptives.

The alteration of people’s behaviors explains the reason behind increased birthrates when people have access to medical marijuana even though the study authors explained that weed has physiological effects that could cause a decrease in fertility.

The researchers further wrote that the increase in the birthrate might be attributed to the fact that behavioral factors can override the physiological effects of marijuana consumption.

The study concludes that the enactment of medical marijuana laws leads to increased sexual activity and reduced use of contraceptives amongst sexually active individuals. These behavioral responses may be due to the effects of enhanced attention on sexual contact after weed consumption and the willingness to participate in sexual activities as well as ignoring the outcome of engaging in any sexual activity.

A recent survey conducted by Lioness showed that marijuana could intensify sexual pleasure and increase libido for both men and women.

Experts say that the stufy findings highlight the far-reaching benefits of marijuana that sector players like Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) hint at as they recommend the full legalization of pot.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Italian Scientists Announce Discovery of Two New Marijuana Cannabinoids

As we rolled into 2020, a team of Italian scientists announced that they had discovered two new cannabinoids in the marijuana plant. This discovery shows that there is much more that remains to be learned about the cannabis plant. Their findings are an addition to the existing knowledge of the controversial plants, even though we are yet to find out the functions of the new compounds and how they affect the human body.

The two compounds found by the scientists include tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP).

The structure of THCP is roughly the same as that of tetrahydrocannabinol (THC), which is the compound responsible for inducing a high. However, THCP is 30 times more potent than THC. When pharmacological tests were conducted on THCP, the compound induced hypomotility, analgesia, catalepsy, and reduced rectal temperature. This shows that its effect on the body is like that of THC. It is unclear if THCP is psychoactive or if it induces the same high as THC, but when it is administered at lower doses in mice, it appeared to be more potent than THC.

The CBDP is associated with CBD, which acts as an antioxidant, anti-inflammatory, anti-convulsant, and reverses the adverse effects of THC.

The authors wrote that CBDP is a phytocannabinoid whose structure is made of a linear alkyl side chain with more than five carbon atoms. Research on the two compounds would be of significant benefit to the scientific world as it would help researchers understand why different marijuana strains have varying effects on the body, which results in a myriad of feeling as well as the promotion of healing and wellness.

The authors wrote in Scientific Reports that there is a growing number of clinical trials and documentation providing real evidence of the ability of marijuana and cannabinoids to treat a wide range of ailments such as insomnia, anxiety, autism, multiple sclerosis, and neuropathic pain. They also added that they expect THCP to bind better to the CB1 receptor cells than the THC.

Cannabis sativa species are more potent than cannabis indica. Cannabis sativa is used to treat glaucoma and epilepsy. This species of marijuana is an invaluable source of nutrients and can also be used for making textiles; however, it is considered to be the most illegal drug all over the globe, especially among young adults. The plant can produce at least 150 phytocannabinoids, with the most commonly known being THC and CBD. Until recently, THC was the only known psychoactive cannabinoid since marijuana strains that were tested contained low levels of THCP and CBDP. However, the researchers noted that higher levels of the two compounds might be found in other breeds of marijuana.

The authors further noted that since the properties and potential capability of THCP and CBDP is unknown, more research should be conducted on the compounds.

Analysts see these findings as vindication for weed companies like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) that have always said that federal authorities should remove all impediments to cannabis research so that the plant can be fully understood.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Leverages Delta Reclaiming System to Target Booming Cannabinoid Market

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, is establishing its position in the thriving cannabinoid market with its trademarked Delta Reclaiming System. The system reclaims ethanol and hydrocarbon-based solvents, among others, for use in hemp-biomass, cannabinoid extraction processes. A recent article discussing the company reads, “HTC’s clean-energy approach gives the company a measure of additional gravitas in a booming industry defined by rapidly shifting public perspectives that have driven communities and states to battle long-established federal drug-industry regulations that many people now regard as onerous. . . . Cannabinoid users are already reporting the benefits of nonpsychoactive cannabinoids in dealing with pain, nerve, muscle disorders and other health issues at the same time that natural product alternatives to the prescription drug market were gaining a strong foothold in the consumer wellness marketplace. Natural-products ,industry-market researchers at data-technology company SPINs reported recently that CBD sales grew 342% year-over-year between August 2018 and August 2019, reaching $185.1 million in revenue — well above the $9.1 million level reported two years ago (http://cnw.fm/E4p1V).”

To view the full article, visit http://cnw.fm/zXd9v

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp-biomass and cannabidiol (“CBD”) industry as well as gas and liquid extraction. HTC’s extraction and purification systems are engineered to large scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.